Boeing (BA) Sees a More Significant Dip Than Broader Market: Some Facts to Know

Boeing closed at $176.06, down 1.37% on the day and roughly 1.04% over the past month, trailing the Aerospace sector (+5.01%) and the S&P 500 (+2.52%). The company is set to report earnings on January 28, 2025, with consensus estimates calling for EPS of -$2.27 (a 382.98% year‑over‑year decline) and revenue of $16.37 billion (down 25.67% YoY). Zacks reports a 1.35% downward revision in the one‑month consensus EPS estimate, assigns Boeing a Zacks Rank of #3 (Hold) and places the Aerospace‑Defense industry at rank 155 (bottom 39%), indicating analyst caution and the potential for further estimate revisions to influence near‑term share momentum.

Analysis

Boeing closed at $176.06, down 1.37% on the session and underperforming the S&P 500 (‑0.29%), Dow (‑0.32%) and Nasdaq (‑0.5%). Over the past month the shares fell 1.04%, lagging the Aerospace sector's +5.01% and the S&P 500's +2.52%, signaling relative weakness ahead of a key earnings print.

The company is scheduled to report on January 28, 2025, with consensus estimates calling for EPS of -$2.27 (a 382.98% year‑over‑year decline) and revenue of $16.37 billion (down 25.67% YoY). Those large negative year‑over‑year moves set up elevated downside risk to sentiment and near‑term valuation if results or guidance miss already reduced expectations.

Analyst momentum is deteriorating: the one‑month consensus EPS estimate fell 1.35% and Zacks assigns Boeing a Rank #3 (Hold) while placing Aerospace‑Defense in the bottom 39% of industries (rank 155). Given research linking estimate revisions to short‑term share momentum, investors should expect heightened volatility into the report and for fresh analyst revisions to drive immediate price moves.

Key Decisions for Investors

• Trim or avoid adding material long positions into the January 28 earnings release given consensus EPS of -$2.27 and materially lower revenue expectations,
• Use options or other hedges to protect existing exposure through the earnings date to guard against downside surprise and volatile estimate‑driven moves,
• Monitor daily analyst estimate revisions and Zacks rank changes—upbeat revisions have historically correlated with short‑term positive momentum while further downgrades would increase downside risk,
• Plan to reassess positions after management commentary and actual results; consider re‑entry only if the company beats consensus and provides credible improvement in revenue or margin outlook